DexCom(US:DXCM) Newsfile·2025-11-11 13:39Core Points - A class action securities lawsuit has been filed against DexCom, Inc. to recover losses for shareholders affected by alleged securities fraud between July 26, 2024, and September 17, 2025 [2] - The lawsuit alleges that DexCom made unauthorized material design changes to its glucose monitoring products, the G6 and G7, which rendered them less reliable and posed health risks to users [3] Company Details - The complaint claims that the defendants overstated the enhancements and reliability of the G7 device, downplayed the severity of issues with the G7, and subjected DexCom to increased regulatory scrutiny and potential legal repercussions [3] - The lawsuit indicates that the public statements made by the defendants were materially false and misleading throughout the relevant time period [3] Next Steps - Shareholders who suffered losses in DexCom, Inc. stock during the specified timeframe are encouraged to seek information about their rights to recovery, with no cost or obligation to participate [4] Legal Representation - Levi & Korsinsky LLP, a recognized securities litigation firm, has a history of securing significant recoveries for shareholders and has been ranked among the top securities litigation firms in the United States [5]